<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04081623</url>
  </required_header>
  <id_info>
    <org_study_id>ROSS Gen 2</org_study_id>
    <nct_id>NCT04081623</nct_id>
  </id_info>
  <brief_title>Trans-abdominal Fetal Pulse Oximetry: Signal Integrity</brief_title>
  <official_title>Trans-abdominal Fetal Pulse Oximetry: Signal Integrity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Raydiant Oximetry, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Raydiant Oximetry, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is set up to advance and integrate the established mathematical principles of&#xD;
      oxygen saturation to model with increasing accuracy the &quot;body in a body&quot; problem of fetus in&#xD;
      mother; similar to existing pulse oximeters,&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigational device is a non-invasive fetal pulse oximeter that measures fetal&#xD;
      arterial pulse signal using safe, noninvasive, transabdominal near-infrared spectroscopy. The&#xD;
      optical sensor will obtain fetal pulse oximetry signals. Women will also undergo sonographic&#xD;
      evaluation to assess distance from maternal skin to fetal tissue and to confirm fetal&#xD;
      presentation and position. There is no change to standard of care procedures for fetal heart&#xD;
      rate monitoring. The fetal heart rate that will be monitored with the investigational device&#xD;
      will be used for research purposes only. Results will not be used to guide or alter patient&#xD;
      management.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Actual">June 8, 2021</completion_date>
  <primary_completion_date type="Actual">May 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fetal signal integrity</measure>
    <time_frame>During NST, BPP, or active labor</time_frame>
    <description>Integrity of the fetal signal relative to background maternal signal and biologic/electronic noise, and related to fetal position, presentation and the depth of the fetus from maternal skin.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">9</enrollment>
  <condition>Fetal Distress</condition>
  <arm_group>
    <arm_group_label>Clinic</arm_group_label>
    <description>This group is undergoing their scheduled visit for Non-Stress Test (NST) or Biophysical Profile (BPP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Labor and Delivery</arm_group_label>
    <description>This group is in active labor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Raydiant Oximetry Sensing System</intervention_name>
    <description>The investigational device is used to record fetal pulse signals.</description>
    <arm_group_label>Clinic</arm_group_label>
    <arm_group_label>Labor and Delivery</arm_group_label>
    <other_name>ROSS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing their scheduled visit to the MFM clinic for a NST/BPP or in latent labor&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant women with singleton pregnancies, vertex presentation&#xD;
&#xD;
          2. Age ≥ 18 years&#xD;
&#xD;
          3. Healthy women ≥ 28 weeks gestation undergoing either Non-Stress test (NST) or&#xD;
             Biophysical profile (BPP) OR&#xD;
&#xD;
          4. Healthy women ≥ 37 weeks in labor&#xD;
&#xD;
          5. Vertex presentation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age &lt;18 years&#xD;
&#xD;
          2. Multiple gestation ( twins, triplets)&#xD;
&#xD;
          3. Presentation other than vertex&#xD;
&#xD;
          4. &lt; 28 weeks of gestation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2019</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Distress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

